Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials recruiting in the U.S.
19 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are recruiting participants at sites across the United States.
Cities with the most studies
- New York City, NY7 studies
- Miami, FL6 studies
- Houston, TX6 studies
- Indio, CA5 studies
- Philadelphia, PA5 studies
- St. Louis, MO5 studies
- New Haven, CT5 studies
- Kansas City, KS5 studies
- Tampa, FL4 studies
- Birmingham, AL4 studies
- Washington, DC4 studies
- Milwaukee, WI4 studies
- Orlando, FL4 studies
- Cleveland, OH4 studies
- San Francisco, CA4 studies
- Seattle, WA3 studies
- Cincinnati, OH3 studies
- Portland, OR3 studies
- Scottsdale, AZ3 studies
- Centennial, CO3 studies
- Austin, TX3 studies
- Boston, MA3 studies
By state
- Alabama4 studies
- Arizona4 studies
- California11 studies
- Colorado5 studies
- Connecticut6 studies
- District of Columbia4 studies
- Florida11 studies
- Illinois4 studies
- Kansas5 studies
- Louisiana3 studies
- Maryland3 studies
- Massachusetts4 studies
- Michigan5 studies
- Missouri5 studies
- New York8 studies
- North Carolina6 studies
- Ohio7 studies
- Oregon3 studies
- Pennsylvania6 studies
- Tennessee3 studies
- Texas10 studies
- Washington3 studies
- Wisconsin4 studies
Recently updated studies
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05327114A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07091630A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06752356Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07032662A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 14, 2026 · NCT07304154Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06968975A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07264426Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Recruiting
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT07478172A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RecruitingObservational study
All ages · Women · Updated Feb 17, 2026 · NCT06299748A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351IVIG vs SCIG in CIDP
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Dec 11, 2025 · NCT05584631A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06538064Biorepository and Registry for Plasma Exchange Patients
RecruitingObservational study
Ages 12 to 99 · All sexes · Updated May 20, 2025 · NCT05004493From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.